说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 补髓生血颗粒
1)  Busuishengxue granule
补髓生血颗粒
1.
The Clinical Effect and Experimental Study on Serum TNF-α of Patients with Chronic Aplastic Anemia Treated by Busuishengxue Granule;
补髓生血颗粒治疗慢性再生障碍性贫血的疗效及对患者血清TNF-α水平的影响
2.
The Clinical Effect and Experimental Study on the NF-κB of Signal Transduction with CAA Treated by Busuishengxue Granule;
补髓生血颗粒治疗慢性再障的疗效及对信号转导因子NF-κB的影响
3.
Objective: To observe the clinical effect of chronic aplastic anemia (CAA) treated with Busuishengxue granule (BSSXG) and the difference in expression levels of LFA-3/CD58, CD11b, Ln and IL-12 before and after treatment.
目的:观察补髓生血颗粒对慢性再障(CAA)的临床疗效及对粘附分子LFA-3/CD58、CD11b、Ln和细胞因子IL-12的影响。
2)  Busui Shengxue Granule
补髓生血颗粒
1.
Effect of Busui Shengxue Granule on Serum Tyrosine Kinase 3 Ligand and Fibronectin in Patients with Chronic Aplastic Anemia;
补髓生血颗粒对慢性再生障碍性贫血患者血清酪氨酸激酶-3配体和纤维连接蛋白的影响
2.
Objective To observe the clinical effect of Busui Shengxue granule (BSSXG) in treating chronic aplastic anemia (CAA) and study its mechanism.
目的 观察补髓生血颗粒治疗慢性再生障碍性贫血(CAA)的临床疗效并探讨其作用机理。
3.
Objective: To observe the clinical effect of Busui Shengxue granule(BSSXG) in treating Myelodyplastic Syndrome-Refractory Anemia(MDS-RA),evaluate the expression of the blood IL-10 before and after treatment, and reveal the pathogenesis of MDS-RA and effect mecheanism of supplement BSSXG on MDS-RA.
目的:观察补髓生血颗粒治疗骨髓增生异常综合征之难治性贫(MDS-RA)的临床疗效,检测患者治疗前后血清IL-10表达的变化,进一步探讨补髓生血颗粒治疗MDS-RA的疗效及对IL-10的影响。
3)  Marrow-supplementing and Blood-engendering Granule
补髓生血颗粒
1.
Effects of Marrow-Supplementing and Blood-Engendering Granule on Bone Marrow and Peripheral Blood of Wistar Rats with Aplastic Anemia;
补髓生血颗粒对再障模型大鼠骨髓病理、造血祖细胞及外周血的影响
2.
Effects of Marrow-supplementing and Blood-engendering Granule Impacting Correlative Adhesion Molecule of Integrin VLA Family
补髓生血颗粒对慢性再障患者整合素VLA亚家族相关粘附分子的影响
3.
This experiment studied 60 rats models suffering from aplastic anemia in order to compare the difference between Marrow-supplementing and Blood-engendering Granule (MSABSEG)(high dose,moderate dose,low dose) and Aplastic Anemi.
本实验为观察补髓生血颗粒对于再生障碍性贫血模型大鼠的外周血细胞、骨髓有核细胞和粒系祖细胞的影响和作用,比较补髓生血颗粒组(高剂量、中剂量、低剂量)分别与再障生血片组治疗再障模型大鼠的上述三项指标的差异,并探讨补髓生血颗粒组(高剂量、中剂量、低剂量)与单纯性造模组相比对于上述三项指标的恢复情况,为此我们针对60只AA模型大鼠进行了观察研究。
4)  Busui Shengxue Granules
补髓生血颗粒
1.
Determination of Lcariin(C_(33)H_(40)O_(15))in Busui Shengxue Granules by RP-HPLC;
RP-HPLC法测定补髓生血颗粒中淫羊藿苷(C_(33)H_(40)O_(15))的含量
2.
To observe the effects and the mechanism of Busui Shengxue granules(补髓生血冲剂)to Chronic Aplastic Anemia(CAA).
目的:探讨补髓生血颗粒对慢性再生障碍性贫血(CAA)患者CD34+细胞及CD34+C-myc细胞表达影响及疗效机理。
5)  Busuishengxue Granules
补髓生血颗粒
1.
Busuishengxue Granules by regulating the bone marrow c-kitmRNA and the expression of CD117 improved the hematopoietic function of bone marrow in CAA.
目的:探讨补髓生血颗粒对慢性再生障碍性贫血(CAA)患者骨髓单个核细胞c-kit mRNA及CD117表达的影响。
2.
Busuishengxue granules improve hematopoietic function of bone marrow in CAA patients and accelerate the recovery of hematopoietic function of bone marrow probably by regulating bone marrow c-met mRNA expression.
目的探讨补髓生血颗粒对慢性再生障碍性贫血(CAA)患者骨髓单个核细胞c-met mRNA表达的影响。
6)  Busuishengxue granule
补髓生血颗粒剂
1.
Objective: This article discussed the clinical effective of Busuishengxue granule to chronic aplastic anemia (CAA) patients, and observed the difference in expression level of myelo-cytokine c-kit/CD117, c-Met/HGF and CD34~+ cell in CAA patients before and after treatment.
目的:探讨补髓生血颗粒剂对慢性再生障碍性贫血(以下简称为CAA)患者的临床疗效及治疗前后骨髓c-kit/CD117、HGF/c-met及CD34~+细胞表达水平的影响。
2.
Objective: This article discussed the clinical effect of Busuishengxue granule to chronic aplastic anemia (CAA) patients, and observed the different expression level of serum cytokine Interleukin-6 (IL-6) in CAA patients before and after treatment.
目的:探讨补髓生血颗粒剂对慢性再生障碍性贫血(以下简称为CAA)患者的临床疗效及其对治疗前后血清IL-6表达水平的影响,进一步揭示CAA发病机制及补肾中药治疗CAA的作用机理。
补充资料:补髓汤

≮美食原料≯

鳖1只,猪脊髓200克,生姜,葱,胡椒粉,味精知适量。

≮美食做法≯

1、将鳖用开水烫死,揭去鳖甲去内脏和头,爪将猪脊髓洗净;

2、将鳖肉放入锅内,加生姜,葱,胡椒粉,用武火烧沸,再用文火将鳖肉煮熟,然后放入猪脊髓,煮熟加味精即成。

≮美食特色≯

吃肉,喝汤,亦可佐餐食用.滋阴补肾,真精补髓.适用于肾阴虚,头昏目眩,腰膝酸痛,多梦遗精等。

说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条